A genomic test may allow millions of breast cancer patients to avoid chemotherapy. The test, described as groundbreaking and revolutionary, could determine which patients can safely skip chemotherapy. Reports suggest that the test has brought relief to some breast cancer patients who have been able to avoid the treatment, although details of the test and its implications are still emerging.